These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8448501)

  • 21. A commentary on "Urine testing in methadone maintenance treatment: applications and limitations".
    Coppola JJ
    J Subst Abuse Treat; 2003 Sep; 25(2):65-6. PubMed ID: 14629985
    [No Abstract]   [Full Text] [Related]  

  • 22. A commentary on "Urine testing in methadone maintenance treatment: applications and limitations".
    Parrino MW
    J Subst Abuse Treat; 2003 Sep; 25(2):71-3. PubMed ID: 14629988
    [No Abstract]   [Full Text] [Related]  

  • 23. A commentary on "Urine testing in methadone maintenance treatment: applications and limitations".
    Heaps MM; Lurigio AJ
    J Subst Abuse Treat; 2003 Sep; 25(2):69-70. PubMed ID: 14629987
    [No Abstract]   [Full Text] [Related]  

  • 24. A commentary on "Urine testing in methadone maintenance treatment: applications and limitations". Thinking outside the urine cup.
    DuPont RL
    J Subst Abuse Treat; 2003 Sep; 25(2):67-8. PubMed ID: 14629986
    [No Abstract]   [Full Text] [Related]  

  • 25. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program.
    Banys P; Tusel DJ; Sees KL; Reilly PM; Delucchi KL
    J Subst Abuse Treat; 1994; 11(3):225-32. PubMed ID: 8072050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retention in methadone maintenance and heroin addicts' risk of death.
    Caplehorn JR; Dalton MS; Cluff MC; Petrenas AM
    Addiction; 1994 Feb; 89(2):203-9. PubMed ID: 8173486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The methadone program in Stockholm is repressive].
    Gunne L
    Lakartidningen; 2001 Jul; 98(28-29):3251-3. PubMed ID: 11496816
    [No Abstract]   [Full Text] [Related]  

  • 28. A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program.
    Avants SK; Margolin A; Mckee S
    J Subst Abuse; 2000; 11(3):215-30. PubMed ID: 11026121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-prescribed drug use during methadone treatment by clinic- and community-based patients.
    Wolff K; Hay AW; Vail A; Harrison K; Raistrick D
    Addiction; 1996 Nov; 91(11):1699-704. PubMed ID: 8972927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
    Tennant F; Shannon J
    J Addict Dis; 1995; 14(1):67-74. PubMed ID: 7632748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine testing in methadone maintenance treatment: applications and limitations.
    Goldstein A; Brown BW
    J Subst Abuse Treat; 2003 Sep; 25(2):61-3. PubMed ID: 14629984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison Between Urinalysis Results and Self-Reported Heroin Use Among Patients Undergoing Methadone Maintenance Treatment in China.
    Li L; Liang LJ; Lin C; Feng N; Wu Z
    Subst Use Misuse; 2017 Aug; 52(10):1307-1314. PubMed ID: 28346039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing opiate abstinence through voucher-based reinforcement therapy.
    Silverman K; Wong CJ; Higgins ST; Brooner RK; Montoya ID; Contoreggi C; Umbricht-Schneiter A; Schuster CR; Preston KL
    Drug Alcohol Depend; 1996 Jun; 41(2):157-65. PubMed ID: 8809505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone dose, plasma level, and cross-tolerance to heroin in man.
    Volavka J; Verebey K; Resnick R; Mulé S
    J Nerv Ment Dis; 1978 Feb; 166(2):104-9. PubMed ID: 627883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of buprenorphine use by heroin addicts undergoing treatment].
    San L; Tremoleda J; Ollé JM; Porta Serra M; de la Torre R
    Med Clin (Barc); 1989 Nov; 93(17):645-8. PubMed ID: 2615545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.